Carol I. Diamanti - Concepedia

Concepedia

Author

Carol I. Diamanti

Stanford University ORCID

Also Known As

C I Diamanti, C. I. DIAMANTI, C. I. Diamanti, CAROL I. DIAMANTI, Carol Diamanti, Carol I Diamanti, Carol I. Diamanti, Cecilia Diamanti, M. W. Sundberg

27

Publications

1.1K

Citations

11

H-Index

43

Concepts

All Affiliations

Stanford University University of California, Davis United States Department of Veterans Affairs

CI

About

Carol I. Diamanti is an author at Stanford University specializing in medicine, radiation oncology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	607
2	Engineering	4	4	326
3	Natural Sciences	4	4	337
4	Health Sciences	1	1	77
5	Allergy	1	1	33

Carol I. Diamanti

×

12

Publications

1.1K

Citations

11

H-Index

	Year	Citations
Conjugation of antibodies with bifunctional chelating agents: Isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ions Claude F. Meares, Michael J. McCall, Dayton T. Reardan, Analytical Biochemistry Metal IonsBiochemistryMedicineBioanalysisBioconjugation	1984	375
Selective binding of metal ions to macromolecules using bifunctional analogs of EDTA M W Sundberg, Claude F. Meares, David A. Goodwin, Journal of Medicinal Chemistry Inorganic ChemistryMetal IonsMolecular SciencesEdtamichael W. SundbergEngineering	1974	174
Indium-111-labeled autologous platelets for location of vascular thrombi in humans. David A. Goodwin, Jerrold T. Bushberg, Paul W. Doherty, Munich Personal RePEc Archive (Ludwig Maximilian University of Munich)	1978	122
Chelating agents for the binding of metal ions to macromolecules M W Sundberg, Claude F. Meares, David A. Goodwin, Nature Metal IonsBiochemistryNatural SciencesMetalloproteinChemistry	1974	88
Use of specific antibody for rapid clearance of circulating blood background from radiolabeled tumor imaging proteins David A. Goodwin, Claude F. Meares, Carol I. Diamanti, European Journal of Nuclear Medicine and Molecular Imaging Nuclear MedicineEngineeringOncologic ImagingBlood BackgroundBiomedical Imaging	1984	77
Bledta II: Synthesis of a new tumor‐visualizing derivative of CO(III)‐bleomycin Leslie H. DeRiemer, Claude F. Meares, David A. Goodwin, Journal of Labelled Compounds and Radiopharmaceuticals Bledta IiChemical BiologyPharmaceutical ChemistryEdta GroupTumor Biology	1981	63
BLEDTA: tumor localization by a bleomycin analog containing a metal-chelating group Leslie H. DeRiemer, Claude F. Meares, David A. Goodwin, Journal of Medicinal Chemistry Antitumor Antibiotic BleomycinPathologyTumor BiologyMedicinal ChemistryOncology	1979	61
Pretargeted immunoscintigraphy: effect of hapten valency on murine tumor uptake. David A. Goodwin, Claude F. Meares, Maureen McTigue, PubMed Immunocytochemical TechniqueEngineeringOncologic ImagingImmunologyPathology	1992	46
Chelate conjugates of monoclonal antibodies for imaging lymphoid structures in the mouse. David A. Goodwin, Claude F. Meares, Michael J. McCall, PubMed Immunocytochemical TechniqueLaboratory ImmunologyImmunologyAlpha Iak MoabImmunophenotyping	1985	33
Clinical studies with In-111 BLEDTA, a tumor-imaging conjugate of bleomycin with a bifunctional chelating agent. David A. Goodwin, Claude F. Meares, Leslie H. DeRiemer, PubMed Background RadioactivityEngineeringOncologic ImagingIn-111 BledtaPathology	1981	29

Page 1